Skip to main content
. 2013 Nov 1;19(13):1452–1458. doi: 10.1089/ars.2013.5307

FIG. 2.

FIG. 2.

Effects of type 2 diabetes on MPO concentration. Serum MPO concentration compared between type 2 diabetic patients and control subjects (A) and between type 2 diabetic patients with or without nephropathy and control subjects (B). *p<0.05. MPO, myeloperoxidase.